Impact of Apolipoprotein E Genotype on Neurocognitive Function in Patients With Brain Metastases: An Analysis of NRG Oncology's RTOG 0614-Reference-Cited by-同舟云学术

Impact of Apolipoprotein E Genotype on Neurocognitive Function in Patients With Brain Metastases: An Analysis of NRG Oncology's RTOG 0614

Published:2023-12 Issue: Volume: Page:
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Wefel Jeffrey S.,Deshmukh Snehal,Brown Paul D.,Grosshans David R.,Sulman Erik P.,Cerhan Jane H.,Mehta Minesh P.,Khuntia Deepak,Shi Wenyin,Mishra Mark V.,Suh John H.,Laack Nadia N.,Chen Yuhchyau,Curtis Amarinthia (Amy),Laba Joanna M.,Elsayed Ahmed,Thakrar Anu,Pugh Stephanie L.,Bruner Deborah W.

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference55 articles.

1. Whole-brain radiotherapy in the management of brain metastasis;Khuntia;J Clin Oncol,2006

2. Radiosurgery alone or in combination with whole-brain radiotherapy for brain metastases;Pirzkall;J Clin Oncol,1998

3. Japanese Radiation Oncology Study Group 99-1 (JROSG 99-1) Investigators. Stereotactic radiosurgery with or without whole-brain radiotherapy for brain metastases: Secondary analysis of the JROSG 99-1 randomized clinical trial;Aoyama;JAMA Oncol,2015

4. Survival in patients with brain metastases: Summary report on the updated diagnosis-specific graded prognostic assessment and definition of the eligibility quotient;Sperduto;J Clin Oncol,2020

5. Effect of radiosurgery alone versus radiosurgery with whole brain radiation therapy on cognitive function in patients with 1 to 3 brain metastases: A randomized clinical trial;Brown;JAMA,2016

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of serum biomarkers with neurocognitive decline after PCI in small cell lung cancer: an exploratory study of the phase III NCT01780675 trial;Clinical Lung Cancer;2024-08